If needed, orthodontic wax applied over braces can help ... You will typically be given an oral antibiotic and a mild painkiller to aid in your recovery. Your healthcare provider also may need to ...

A virulent strain of antibiotic-resistant ‘superbug’ bacteria that causes severe disease has been found circulating in a Malaysian hospital, a new study by academics has revealed. The threat ...

Researchers believe they have identified a new class of antibiotics, nearly three decades since the last new one came to market. Teams at McMaster University in Ontario, Canada and the University ...

He says that to find new drugs to combat growing antimicrobial resistance, scientists must “look to more unusual or overlooked sources of antibiotics.” So the team grew the bacteria found in ...

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...

The last time a new class of antibiotics reached the market was almost three decades ago – but that could soon change, thanks to a discovery by researchers at McMaster University, Hamilton, Ontario.

Get Instant Summarized Text (Gist) The US has approved a new antibiotic, Blujepa, for treating uncomplicated urinary tract infections in women and girls aged 12 and older. This marks the ...

Researchers have discovered a new antibiotic molecule that targets a broad range of disease-causing bacteria — even strains resistant to commercial drugs — and is not toxic to human cells 1.

UIC researchers working with collaborators at McMaster University in Canada determined how the new antibiotic works and why the drug evades bacterial resistance. "The holy grail in the field is to ...

It is the first in a new class of oral antibiotics approved for this condition in nearly 30 years. UTIs are common bladder infections that typically affect women without underlying health issues.

Blujepa is the first in a new class of oral antibiotics in 30 years. It is expected to launch in the second half of 2025 in the United States. GSK announced that the FDA has approved Blujepa ...

The FDA on Tuesday approved GSK’s oral antibiotic gepotidacin for the treatment of uncomplicated urinary tract infections. The drug will be marketed under the brand name Blujepa. GSK plans to launch ...